Literature DB >> 19784953

A novel approach to tag and identify geranylgeranylated proteins.

Lai N Chan1, Courtenay Hart, Lea Guo, Tamara Nyberg, Brandon S J Davies, Loren G Fong, Stephen G Young, Brian J Agnew, Fuyuhiko Tamanoi.   

Abstract

A recently developed proteomic strategy, the "GG-azide"-labeling approach, is described for the detection and proteomic analysis of geranylgeranylated proteins. This approach involves metabolic incorporation of a synthetic azido-geranylgeranyl analog and chemoselective derivatization of azido-geranylgeranyl-modified proteins by the "click" chemistry, using a tetramethylrhodamine-alkyne. The resulting conjugated proteins can be separated by 1-D or 2-D and pH fractionation, and detected by fluorescence imaging. This method is compatible with downstream LC-MS/MS analysis. Proteomic analysis of conjugated proteins by this approach identified several known geranylgeranylated proteins as well as Rap2c, a novel member of the Ras family. Furthermore, prenylation of progerin in mouse embryonic fibroblast cells was examined using this approach, demonstrating that this strategy can be used to study prenylation of specific proteins. The "GG-azide"-labeling approach provides a new tool for the detection and proteomic analysis of geranylgeranylated proteins, and it can readily be extended to other post-translational modifications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784953      PMCID: PMC2855049          DOI: 10.1002/elps.200900259

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  41 in total

Review 1.  Therapeutic intervention based on protein prenylation and associated modifications.

Authors:  Michael H Gelb; Lucas Brunsveld; Christine A Hrycyna; Susan Michaelis; Fuyuhiko Tamanoi; Wesley C Van Voorhis; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2006-10       Impact factor: 15.040

2.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization.

Authors:  Uyen T T Nguyen; Janina Cramer; Joaquin Gomis; Reinhard Reents; Marta Gutierrez-Rodriguez; Roger S Goody; Kirill Alexandrov; Herbert Waldmann
Journal:  Chembiochem       Date:  2007-03-05       Impact factor: 3.164

4.  Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Martin O Bergo; Julia I Toth; Xin Qiao; Yan Hu; Salemiz Sandoval; Margarita Meta; Pravin Bendale; Michael H Gelb; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-12       Impact factor: 11.205

5.  Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

Authors:  Kian-Huat Lim; Kevin O'Hayer; Stacey J Adam; S Disean Kendall; Paul M Campbell; Channing J Der; Christopher M Counter
Journal:  Curr Biol       Date:  2006-12-19       Impact factor: 10.834

6.  Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins.

Authors:  Simona Paganini; Gianni Francesco Guidetti; Silvia Catricalà; Piera Trionfini; Simona Panelli; Cesare Balduini; Mauro Torti
Journal:  Biochimie       Date:  2005-09-21       Impact factor: 4.079

7.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation.

Authors:  Shao H Yang; Margarita Meta; Xin Qiao; David Frost; Joy Bauch; Catherine Coffinier; Sharmila Majumdar; Martin O Bergo; Stephen G Young; Loren G Fong
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

8.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

9.  In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.

Authors:  Jie Lu; Lai Chan; Hannah D G Fiji; Russell Dahl; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

10.  Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.

Authors:  Wolfgang Benetka; Manfred Koranda; Sebastian Maurer-Stroh; Fritz Pittner; Frank Eisenhaber
Journal:  BMC Biochem       Date:  2006-02-28       Impact factor: 4.059

View more
  26 in total

1.  Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.

Authors:  Amanda J DeGraw; Charuta Palsuledesai; Joshua D Ochocki; Jonathan K Dozier; Stepan Lenevich; Mohammad Rashidian; Mark D Distefano
Journal:  Chem Biol Drug Des       Date:  2010-10-11       Impact factor: 2.817

Review 2.  Exploring protein lipidation with chemical biology.

Authors:  Howard C Hang; Maurine E Linder
Journal:  Chem Rev       Date:  2011-09-16       Impact factor: 60.622

Review 3.  Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions.

Authors:  Elaina A Zverina; Corissa L Lamphear; Elia N Wright; Carol A Fierke
Journal:  Curr Opin Chem Biol       Date:  2012-11-08       Impact factor: 8.822

4.  Bioorthogonal chemical reporters for analyzing protein lipidation and lipid trafficking.

Authors:  Howard C Hang; John P Wilson; Guillaume Charron
Journal:  Acc Chem Res       Date:  2011-06-15       Impact factor: 22.384

5.  Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.

Authors:  Norbert Berndt; Saïd M Sebti
Journal:  Nat Protoc       Date:  2011-10-27       Impact factor: 13.491

6.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

7.  Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.

Authors:  Joshua D Ochocki; Mark D Distefano
Journal:  Medchemcomm       Date:  2013-03       Impact factor: 3.597

8.  Regioselective covalent immobilization of catalytically active glutathione S-transferase on glass slides.

Authors:  Rajesh Viswanathan; Guillermo R Labadie; C Dale Poulter
Journal:  Bioconjug Chem       Date:  2013-03-26       Impact factor: 4.774

9.  A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins.

Authors:  Charuta C Palsuledesai; Joshua D Ochocki; Todd W Markowski; Mark D Distefano
Journal:  Mol Biosyst       Date:  2014-05

10.  Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform.

Authors:  Guillaume Charron; Melody M H Li; Margaret R MacDonald; Howard C Hang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.